HtrA Protease Family as Therapeutic Targets
Journal:
Current Pharmaceutical Design
Volume:
19
Page:
977-1009
Author(s):
Joanna Skorko-Glonek, Dorota Zurawa-Janicka, Tomasz Koper, Miroslaw Jarzab, Donata Figaj, Przemyslaw Glaza and Barbara Lipinska
Plasmodium Drug Targets Outside the Genetic Control of the Parasite
Journal:
Current Pharmaceutical Design
Volume:
19
Page:
282-289
Author(s):
David J. Sullivan
Viral Encephalitis: Current Treatments and Future Perspectives
Journal:
Central Nervous System Agents in Medicinal Chemistry
Volume:
12
Page:
277-285
Author(s):
Renan Barros Domingues
Substance Abuse and Movement Disorders: Complex Interactions and Comorbidities
Journal:
Current Drug Abuse Reviews
Volume:
5
Page:
243-253
Author(s):
Andres Deik, Rachel Saunders-Pullman and Marta San Luciano
Targeted Radiotherapy for Malignant Gliomas
Journal:
Current Drug Discovery Technologies
Volume:
9
Page:
268-279
Author(s):
Daniel S. Oh, David C. Adamson and John P. Kirkpatrick
Nonstandard Drugs and Feasible New Interventions for Autoimmune Hepatitis: Part II
Journal:
Inflammation & Allergy - Drug Targets (Discontinued)
Volume:
11
Page:
351-363
Author(s):
Albert J. Czaja
Angiogenesis as a therapeutic target in breast cancer
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
12
Page:
1230-1238
Author(s):
Angelos K. Koutras, Ioannis Starakis, Dionysia Lymperatou and Haralabos P. Kalofonos
Immune Therapy of Multiple Sclerosis - Future Strategies
Journal:
Current Pharmaceutical Design
Volume:
18
Page:
4489-4497
Author(s):
Sven G. Meuth, Kerstin Gobel and Heinz Wiendl
Animal Models in Neurology: Drawbacks and Opportunities
Journal:
Current Pharmaceutical Design
Volume:
18
Page:
4443-4452
Author(s):
Robert Patejdl and Uwe K. Zettl
Monoclonal Antibodies in the Treatment of Neuroimmunological Diseases
Journal:
Current Pharmaceutical Design
Volume:
18
Page:
4498-4507
Author(s):
Paulus S. Rommer, Robert Patejdl and Uwe K. Zettl